Sonoma Pharmaceuticals In...

NASDAQ: SNOA · Real-Time Price · USD
5.32
0.05 (0.95%)
At close: Aug 15, 2025, 3:59 PM
5.20
-2.26%
After-hours: Aug 15, 2025, 07:58 PM EDT

Sonoma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
4.01M 3.75M 3.56M 3.58M 3.39M 3.44M 3.14M 2.73M 3.43M 3.01M 2.94M 3.33M 3.98M 2.3M 2.9M 3.74M 3.68M 2.16M 4.94M 5.77M 7.25M
Cost of Revenue
2.55M 2.23M 2.29M 2.22M 2.08M 2.35M 1.68M 1.74M 2.22M 2.15M 2.11M 2M 2.54M 2.2M 1.7M 2.5M 2.23M 2.35M 2.94M 3.27M 4.29M
Gross Profit
1.46M 1.53M 1.27M 1.36M 1.31M 1.09M 1.46M 990K 1.2M 864K 831K 1.34M 1.45M 96K 1.2M 1.24M 1.45M -194K 2M 2.5M 2.96M
Operating Income
-1.09M -656K -1.03M -850K -1.17M -1.41M -844K -1.21M -1.24M -1.15M -1.83M -731K -855K -3.06M -958K -964K -904K -2.81M -138K 169K 118K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a 12K 1K 3K n/a n/a n/a n/a n/a 2K 3K 8K 2K
Pretax Income
-1.24M -528K -919K -463K -997K -1.36M -923K -1.3M -1.45M -1.44M -1.91M -917K -922K -3.28M -944K -95K -1.1M -2.72M -626K 151K 39K
Net Income
-1.24M -776K -928K -610K -1.14M -1.07M -866K -1.48M -1.42M -1.31M -1.94M -1.02M -887K -2.94M -944K -100K -1.1M -3.66M -650K 120K 993K
Selling & General & Admin
1.97M 1.77M 1.87M 1.71M 2.01M 2.09M 1.7M 1.66M 2.12M 1.81M 2.67M 2.07M 2.29M 3.15M 2.13M 2.19M 2.27M 2.49M 2.1M 2.42M 2.37M
Research & Development
594K 411K 427K 506K 470K 409K 601K 536K 325K 201K 400K 200K 6K 4K 26K 10K 84K 130K 33K -85K 476K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -73K -189K n/a n/a 11K n/a n/a n/a n/a n/a n/a
Operating Expenses
2.56M 2.18M 2.3M 2.21M 2.48M 2.5M 2.3M 2.2M 2.44M 2.01M 2.67M 2.07M 2.3M 3.16M 2.16M 2.21M 2.36M 2.62M 2.13M 2.33M 2.85M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 292K 1K 3K n/a 9K 3K 4K 1K n/a 5K 4K 2K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 156K n/a n/a n/a 156K n/a n/a n/a 86K n/a n/a n/a 41K n/a n/a n/a
Cost & Expenses
5.11M 4.41M 4.59M 4.43M 4.56M 4.85M 3.98M 3.94M 4.67M 4.16M 4.78M 4.06M 4.84M 5.36M 3.86M 4.71M 4.59M 4.97M 5.07M 5.6M 7.14M
Income Tax Expense
-1K 248K 9K 147K 146K -292K -57K 186K -33K -131K 34K 100K -35K -338K 3K 5K 1K 1.03M n/a n/a -1.11M
Shares Outstanding (Basic)
1.64M 1.24M 1.46M 1.03M 851.45K 780.37K 545.45K 516.4K 493.6K 467.81K 310.7K 310.1K 310.1K 277.04K 308K 234.4K 209.3K 208.5K 205.2K 200.8K 183.9K
Shares Outstanding (Diluted)
1.64M 1.24M 1.46M 1.03M 851.45K 780.37K 545.45K 516.4K 493.6K 467.81K 310.7K 310.1K 310.1K 277.04K 308K 234.4K 209.3K 208.5K 205.2K 215.9K 184.3K
EPS (Basic)
-0.76 -0.63 -0.63 -0.59 -1.34 -1.37 -1.59 -2.87 -2.87 -2.8 -6.24 -3.28 -2.86 -10.63 -3.06 -0.43 -5.25 -17.55 -3.05 0.60 -3.02
EPS (Diluted)
-0.76 -0.63 -0.63 -0.59 -1.34 -1.37 -1.59 -2.87 -2.87 -2.8 -6.24 -3.28 -2.86 -10.63 -3.06 -0.43 -5.25 -17.55 -3.05 0.56 -3.02
EBITDA
-1.09M -625K -998K -815K -1.13M -1.37M -799K -1.16M -1.2M -1.11M -1.8M -703K -824K -3.01M -921K -912K -856K -2.68M -58K 223K -612K
EBIT
-1.24M -656K -1.03M -850K -1.17M -1.41M -844K -1.21M -1.24M -1.15M -1.83M -731K -855K -3.06M -958K -964K -904K -2.72M -138K 169K -665K
Depreciation & Amortization
36K 31K 33K 35K 39K 41K 45K 45K 45K 207K 32K 28K 31K 272K 37K 52K 48K 40K 80K 54K 53K